| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.093 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |